Chemours Co. Aktie News

Chemours remains challenged by weak end markets, but progress on environmental liabilities and Opteon growth support medium-term prospects. Q3 results were mixed, with disruptions impacting earnings, but the resolution of outages and Opteon gains in the TSS segment provide optimism for improvement. TT segment struggles with weak construction activity, but price increases and supply rationalizat...

The Chemours Company ( CC ) Q3 2025 Earnings Call November 7, 2025 8:00 AM EST Company Participants Brandon Ontjes - Vice President of Investor Relations Denise Dignam - President, CEO & Director Shane Hostetter - Senior VP & CFO Conference Call Participants John McNulty - BMO Capital Markets Equity Research Peter Osterland - Truist Securities, Inc., Research Division John Ezekiel Roberts - Miz...

Earnings were light, driven by slowing sales of titanium dioxide, a key component of white paint.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--The Chemours Company Reports Third Quarter 2025 Results.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Fourth Quarter Dividend.

Chemours Company (CC) remains a speculative 'Buy' ahead of Q3. CC offers significant upside potential, driven by Opteon growth, market recovery, and the recent settlement of major legacy liabilities. Despite elevated leverage and earnings volatility, I see no immediate financial distress and expect improving fundamentals through 2027E.

WILMINGTON, Del.--(BUSINESS WIRE)---- $CC--Chemours Announces Dates for Third Quarter 2025 Earnings Release and Webcast Conference Call.

Luminus Management LLC reduced its stake in The Chemours Company (CC -1.86%) during Q3 2025, selling shares worth an estimated $4.30 million, based on the average quarterly price, according to an SEC filing dated October 3, 2025.